PVR and hepatocellular carcinoma: In two HCC cell lines (HepG2.2.15 and MHCC-LM3), we found that blockade of PVR or PVRL2 increased immune cell-mediated lysis of tumour cell, with the combination group showing a higher enhancement effect (Figures 6A, B).